KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Deferred Tax Liability (2016 - 2025)

Jazz Pharmaceuticals has reported Non-Current Deferred Tax Liability over the past 14 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 57.43% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, up 57.43% year-over-year, with the annual reading at $1.1 billion for FY2025, 57.43% up from the prior year.
  • Non-Current Deferred Tax Liability was $1.1 billion for Q4 2025 at Jazz Pharmaceuticals, up from $629.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $1.5 billion in Q4 2022 and troughed at $109.9 million in Q1 2021.
  • The 5-year median for Non-Current Deferred Tax Liability is $879.2 million (2023), against an average of $926.9 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 1011.84% in 2022 and later crashed 43.23% in 2023.
  • Tracing JAZZ's Non-Current Deferred Tax Liability over 5 years: stood at $1.3 billion in 2021, then rose by 14.81% to $1.5 billion in 2022, then crashed by 43.23% to $847.7 million in 2023, then fell by 20.17% to $676.7 million in 2024, then surged by 57.43% to $1.1 billion in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $1.1 billion, $629.0 million, and $682.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.